GlassScriptPhysician profile
Kris Miguel Cajipe
NPI 1912327198
$4,502.97
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $1,618 · 2021: $1,040 · 2022: $723 · 2023: $557 · 2024: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794 · Travel and Lodging: $17.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.58 |
| Travel and Lodging | $17.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $851.69 | 2021-2024 | Urolift |
| Caldera Medical, INC | $811.98 | 2020-2021 | |
| Coloplast Corp | $780.60 | 2019-2024 | |
| Procept Biorobotics Corporation | $237.69 | 2022-2023 | Aquabeam Robotic System |
| Intuitive Surgical, INC. | $237.22 | 2019-2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $198.59 | 2020-2023 | Myrbetriq |
| Allergan, INC. | $193.38 | 2020-2022 | |
| Axonics, INC. | $159.47 | 2022-2024 | Axonics |
| Endo Pharmaceuticals INC. | $151.13 | 2020-2024 | Xiaflex, Aveed |
| Aytu Biopharma, INC. | $120.63 | 2019 | |
| Boston Scientific Corporation | $71.73 | 2022-2024 | Spaceoar Vue System - 10ml |
| Alnylam Pharmaceuticals INC. | $71.39 | 2023 | Givlaari |
| Urovant Sciences INC | $58.47 | 2022 | |
| Urogen Pharma, INC. | $54.52 | 2022-2023 | Jelmyto |
| Conmed Corporation | $50.00 | 2023 | Airseal |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $48.27 | 2024 | Illuccix |
| C. R. Bard, INC. & Subsidiaries | $45.67 | 2022-2023 | Bard Urinary Drainage Bag |
| Progenics Pharmaceuticals, INC. | $45.44 | 2023 | Pylarify |
| Angiodynamics, INC. | $43.29 | 2022 | |
| Olympus America INC. | $41.43 | 2023-2024 | Itind System |
| Myovant Sciences INC. | $40.91 | 2021 | |
| Neotract INC. | $27.47 | 2019-2020 | |
| Calyxo, INC. | $22.62 | 2024 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $22.31 | 2023 | Gemtesa |
| Laborie Medical Technologies Corp. | $19.16 | 2023 | |
| Rochester Medical Corporation | $18.78 | 2022 | |
| 180 Medical, INC. | $18.10 | 2023 | Gentlecath |
| Abbvie INC. | $17.50 | 2023 | Botox |
| Medtronic, INC. | $16.22 | 2024 | Interstim |
| Verity Pharmaceuticals INC. | $15.65 | 2022 | |
| Dentsply Ih INC. | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kris Miguel Cajipe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.